These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 21709195

  • 1. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD, Fukuda E, Fregnani JH, Nonogaki S, Montagnini AL, da Costa WL, Soares FA.
    J Clin Oncol; 2011 Aug 01; 29(22):3030-6. PubMed ID: 21709195
    [Abstract] [Full Text] [Related]

  • 2. High expression of HER3 is associated with a decreased survival in gastric cancer.
    Hayashi M, Inokuchi M, Takagi Y, Yamada H, Kojima K, Kumagai J, Kawano T, Sugihara K.
    Clin Cancer Res; 2008 Dec 01; 14(23):7843-9. PubMed ID: 19047113
    [Abstract] [Full Text] [Related]

  • 3. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX, Ding L, Lin Y, Shu M, Wen JM, Xue L.
    J Clin Pathol; 2015 May 01; 68(5):374-80. PubMed ID: 25731189
    [Abstract] [Full Text] [Related]

  • 4. Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast.
    Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ.
    Clin Cancer Res; 2005 Mar 15; 11(6):2163-8. PubMed ID: 15788662
    [Abstract] [Full Text] [Related]

  • 5. Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.
    Wiseman SM, Makretsov N, Nielsen TO, Gilks B, Yorida E, Cheang M, Turbin D, Gelmon K, Huntsman DG.
    Cancer; 2005 May 01; 103(9):1770-7. PubMed ID: 15770691
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of HER1 amplification with poor prognosis in well differentiated gastric carcinomas.
    Kandel C, Leclair F, Bou-Hanna C, Laboisse CL, Mosnier JF.
    J Clin Pathol; 2014 Apr 01; 67(4):307-12. PubMed ID: 24218028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
    Bartlett JM, Munro A, Cameron DA, Thomas J, Prescott R, Twelves CJ.
    J Clin Oncol; 2008 Nov 01; 26(31):5027-35. PubMed ID: 18768436
    [Abstract] [Full Text] [Related]

  • 11. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
    Steffensen KD, Waldstrøm M, Andersen RF, Olsen DA, Jeppesen U, Knudsen HJ, Brandslund I, Jakobsen A.
    Int J Oncol; 2008 Jul 01; 33(1):195-204. PubMed ID: 18575766
    [Abstract] [Full Text] [Related]

  • 12. ErbB-3 predicts survival in ovarian cancer.
    Tanner B, Hasenclever D, Stern K, Schormann W, Bezler M, Hermes M, Brulport M, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Steiner E, Sehouli J, Edelmann J, Läuter J, Lessig R, Krishnamurthi K, Ullrich A, Hengstler JG.
    J Clin Oncol; 2006 Sep 10; 24(26):4317-23. PubMed ID: 16896008
    [Abstract] [Full Text] [Related]

  • 13. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
    Lee CM, Shrieve DC, Zempolich KA, Lee RJ, Hammond E, Handrahan DL, Gaffney DK.
    Gynecol Oncol; 2005 Nov 10; 99(2):415-21. PubMed ID: 16157365
    [Abstract] [Full Text] [Related]

  • 14. HER3 overexpression and survival in solid tumors: a meta-analysis.
    Ocana A, Vera-Badillo F, Seruga B, Templeton A, Pandiella A, Amir E.
    J Natl Cancer Inst; 2013 Feb 20; 105(4):266-73. PubMed ID: 23221996
    [Abstract] [Full Text] [Related]

  • 15. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
    He WL, Li YH, Yang DJ, Song W, Chen XL, Liu FK, Wang Z, Li W, Chen W, Chen CY, He YL, Zhan WH.
    Eur J Surg Oncol; 2013 Feb 20; 39(2):141-9. PubMed ID: 22999412
    [Abstract] [Full Text] [Related]

  • 16. The upgraded role of HER3 and HER4 receptors in breast cancer.
    Koutras AK, Fountzilas G, Kalogeras KT, Starakis I, Iconomou G, Kalofonos HP.
    Crit Rev Oncol Hematol; 2010 May 20; 74(2):73-8. PubMed ID: 19481955
    [Abstract] [Full Text] [Related]

  • 17. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R.
    Cancer J Sci Am; 1997 May 20; 3(1):21-30. PubMed ID: 9072304
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer].
    Li G, Gu RM, Wen X, Ming XZ, Xia L, Xu XY, Zhang J, Chen HQ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul 20; 16(7):668-72. PubMed ID: 23888453
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
    Gilbertson RJ, Perry RH, Kelly PJ, Pearson AD, Lunec J.
    Cancer Res; 1997 Aug 01; 57(15):3272-80. PubMed ID: 9242460
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
    Koutras AK, Kalogeras KT, Dimopoulos MA, Wirtz RM, Dafni U, Briasoulis E, Pectasides D, Gogas H, Christodoulou C, Aravantinos G, Zografos G, Timotheadou E, Papakostas P, Linardou H, Razis E, Economopoulos T, Kalofonos HP, Fountzilas G, Hellenic Cooperative Oncology Group (HeCOG).
    Br J Cancer; 2008 Dec 02; 99(11):1775-85. PubMed ID: 18985033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.